Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β/Smad Signaling. The Review of Diabetic Studies , [S. l.], p. 62–76, 2026. DOI: 10.70082/y1zx3j95. Disponível em: https://www.diabeticstudies.org/index.php/RDS/article/view/2052. Acesso em: 12 jun. 2026.